Sign in

CIK 0001420565

  • Non-accelerated filer
  • Smaller reporting company

Rein Therapeutics, Inc.

Sign in to watch
Ticker
RNTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
134196017
Phone
+1 737-802-1989
Business address
12407 N. MOPAC EXPY., SUITE 250 #390, AUSTIN, TX, 78758
Former names
Aileron Therapeutics, Inc., AILERON THERAPEUTICS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2017-07-05 Gallagher Brian M. Jr. Director Conversion · Series F Preferred Stock −1,979,188 0
2017-07-05 Sigma Emerging Markets Ltd. 10% owner Conversion +233,086 233,086
2017-07-05 Sigma Emerging Markets Ltd. 10% owner Purchase +190,000 $15.00 $2.9M 423,086
2017-07-05 Sigma Emerging Markets Ltd. 10% owner Conversion · Series F Preferred Stock −2,316,176 0
2017-07-05 EXCEL MEDICAL FUND LP 10% owner Conversion +956,100 956,100
2017-07-05 EXCEL MEDICAL FUND LP 10% owner Purchase +60,000 $15.00 $900K 1,016,100
2017-07-05 EXCEL MEDICAL FUND LP 10% owner Conversion · Series D Preferred Stock −5,934,050 0
2017-07-05 EXCEL MEDICAL FUND LP 10% owner Conversion · Series E-2 Preferred Stock −1,329,993 0
2017-07-05 EXCEL MEDICAL FUND LP 10% owner Conversion · Series E-3 Preferred Stock −1,153,606 0
2017-07-05 EXCEL MEDICAL FUND LP 10% owner Conversion · Series F Preferred Stock −1,083,119 0
2017-07-05 Satter Muneer A 10% owner Conversion +144,773 144,773
2017-07-05 Satter Muneer A 10% owner Purchase +33,333 $15.00 $500K 178,106
2017-07-05 Satter Muneer A 10% owner Conversion · Series D Preferred Stock −847,721 0
2017-07-05 Satter Muneer A 10% owner Conversion · Series E-2 Preferred Stock −183,944 0
2017-07-05 Satter Muneer A 10% owner Conversion · Series E-3 Preferred Stock −159,548 0
2017-07-05 Satter Muneer A 10% owner Conversion · Series F Preferred Stock −247,398 0
2017-07-05 KCK LTD. 10% owner Conversion +446,817 446,817
2017-07-05 KCK LTD. 10% owner Purchase +200,000 $15.00 $3.0M 646,817
2017-07-05 KCK LTD. 10% owner Conversion · Series E-3 Preferred Stock −3,676,471 0
2017-07-05 KCK LTD. 10% owner Conversion · Series F Preferred Stock −763,552 0

Page 14 of 16 · 320 trades